140 related articles for article (PubMed ID: 22965877)
1. NUB1 modulation of GSK3β reduces tau aggregation.
Richet E; Pooler AM; Rodriguez T; Novoselov SS; Schmidtke G; Groettrup M; Hanger DP; Cheetham ME; van der Spuy J
Hum Mol Genet; 2012 Dec; 21(24):5254-67. PubMed ID: 22965877
[TBL] [Abstract][Full Text] [Related]
2. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
[TBL] [Abstract][Full Text] [Related]
3. Negative Regulator of Ubiquitin-Like Protein 1 modulates the autophagy-lysosomal pathway via p62 to facilitate the extracellular release of tau following proteasome impairment.
Guarascio R; Salih D; Yasvoina M; Edwards FA; Cheetham ME; van der Spuy J
Hum Mol Genet; 2020 Jan; 29(1):80-96. PubMed ID: 31691796
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
5. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
[TBL] [Abstract][Full Text] [Related]
6. The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta.
Lin YT; Cheng JT; Liang LC; Ko CY; Lo YK; Lu PJ
J Neurochem; 2007 Oct; 103(2):802-13. PubMed ID: 17680984
[TBL] [Abstract][Full Text] [Related]
7. WW domain-containing oxidoreductase promotes neuronal differentiation via negative regulation of glycogen synthase kinase 3β.
Wang HY; Juo LI; Lin YT; Hsiao M; Lin JT; Tsai CH; Tzeng YH; Chuang YC; Chang NS; Yang CN; Lu PJ
Cell Death Differ; 2012 Jun; 19(6):1049-59. PubMed ID: 22193544
[TBL] [Abstract][Full Text] [Related]
8. Axin negatively affects tau phosphorylation by glycogen synthase kinase 3beta.
Stoothoff WH; Bailey CD; Mi K; Lin SC; Johnson GV
J Neurochem; 2002 Nov; 83(4):904-13. PubMed ID: 12421363
[TBL] [Abstract][Full Text] [Related]
9. Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3β.
Martin L; Page G; Terro F
Neurochem Int; 2011 Aug; 59(2):235-50. PubMed ID: 21672577
[TBL] [Abstract][Full Text] [Related]
10. Kidins220 accumulates with tau in human Alzheimer's disease and related models: modulation of its calpain-processing by GSK3β/PP1 imbalance.
López-Menéndez C; Gamir-Morralla A; Jurado-Arjona J; Higuero AM; Campanero MR; Ferrer I; Hernández F; Ávila J; Díaz-Guerra M; Iglesias T
Hum Mol Genet; 2013 Feb; 22(3):466-82. PubMed ID: 23118350
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3Zeta does not increase GSK3beta-mediated tau phosphorylation in cell culture models.
Matthews TA; Johnson GV
Neurosci Lett; 2005 Aug; 384(3):211-6. PubMed ID: 15963640
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism.
Li T; Paudel HK
Biochemistry; 2006 Mar; 45(10):3125-33. PubMed ID: 16519507
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta.
Li T; Hawkes C; Qureshi HY; Kar S; Paudel HK
Biochemistry; 2006 Mar; 45(10):3134-45. PubMed ID: 16519508
[TBL] [Abstract][Full Text] [Related]
14. Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3beta activation and caspase 3 cleavage.
Chun W; Waldo GS; Johnson GV
J Neurochem; 2007 Dec; 103(6):2529-39. PubMed ID: 17908237
[TBL] [Abstract][Full Text] [Related]
15. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.
Kawakami F; Shimada N; Ohta E; Kagiya G; Kawashima R; Maekawa T; Maruyama H; Ichikawa T
FEBS J; 2014 Jan; 281(1):3-13. PubMed ID: 24165324
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of tau aggregation by cdk5 and GSK3β.
Lee S; Hall GF; Shea TB
J Alzheimers Dis; 2011; 26(2):355-64. PubMed ID: 21677377
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding.
Cho JH; Johnson GV
J Biol Chem; 2003 Jan; 278(1):187-93. PubMed ID: 12409305
[TBL] [Abstract][Full Text] [Related]
18. Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules.
Cho JH; Johnson GV
J Neurochem; 2004 Jan; 88(2):349-58. PubMed ID: 14690523
[TBL] [Abstract][Full Text] [Related]
19. Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3β signaling pathway.
Deng J; Habib A; Obregon DF; Barger SW; Giunta B; Wang YJ; Hou H; Sawmiller D; Tan J
J Neurochem; 2015 Nov; 135(3):630-7. PubMed ID: 26342176
[TBL] [Abstract][Full Text] [Related]
20. Thr175-phosphorylated tau induces pathologic fibril formation via GSK3β-mediated phosphorylation of Thr231 in vitro.
Moszczynski AJ; Gohar M; Volkening K; Leystra-Lantz C; Strong W; Strong MJ
Neurobiol Aging; 2015 Mar; 36(3):1590-9. PubMed ID: 25573097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
